Glyn Edwards is Chief Executive Officer of Summit Therapeutics plc. Mr. Edwards was appointed to the board of directors as Chief Executive Officer in April 2012. Mr. Edwards has a wealth of experience garnered from a 30-year career in the life sciences industry, during which time he has held a number of senior executive and business development roles. Prior to joining Summit, he was Interim Chief Executive Officer of the U.K. trade body the BioIndustry Association — BIA — and Chief Executive Officer at Antisoma plc for 13 years, and Vice President of Business Development at Therapeutic Antibodies Ltd. Mr. Edwards holds a Bachelor of Science in biochemistry from Bristol University and a Master of Science in economics from the London Business School.
Interview with the CEO: Summit Therapeutics plc (SMMT)
July 24, 2015
Glyn Edwards - Antisoma Plc (lse:asm.l)
August 28, 2000